WO2025257758 - SOLID STATE FORMS OF NAVACAPRANT
National phase entry is expected:
Publication Number
WO/2025/257758
Publication Date
18.12.2025
International Application No.
PCT/IB2025/055980
International Filing Date
11.06.2025
Title **
[English]
SOLID STATE FORMS OF NAVACAPRANT
[French]
FORMES À L'ÉTAT SOLIDE DE NAVACAPRANT
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
MUTHUSAMY, Anantha Rajmohan
SOMASUNDARAM, Meenakshi Sundaram
KAUSHIK, Babita
Priority Data
202411045161
11.06.2024
IN
202411046810
18.06.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2416 | |
| EPO | Filing, Examination, Granting | 13355 | |
| Japan | Filing, Examination, Granting | 2462 | |
| South Korea | Filing, Examination, Granting | 2726 | |
| USA | Filing, Examination, Granting | 8740 |

Total:
29,699
Contact Us
Abstract[English]
The present disclosure relates to solid state forms of Navacaprant salts, such as Navacaprant L-tartrate and Navacaprant hydrochloride. In embodiments crystalline polymorphs or salts of Navacaprant, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.[French]
La présente divulgation concerne des formes à l'état solide de sels de navacaprant, tels que le L-tartrate de navacaprant et le chlorhydrate de navacaprant. Des modes de réalisation de la présente divulgation concerne des polymorphes cristallins ou des sels de navacaprant, leurs procédés de préparation, des compositions pharmaceutiques de ceux-ci et leurs procédés d'utilisation.